Chagas Disease Drug Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC687

Introduction

Chagas disease is tropical parasitic disease caused by trypanosoma cruzi. Chagas disease is transferred by triatomine bugs or kissing bugs. Chagas disease can also spread through mother to fetus during pregnancy, blood transfusions, and sometimes from organ transplantation. The symptoms of this disease in early stage are headache, fever, swollen lymph nodes, and others. The chronic symptom appears after 8-12 weeks including enlargement of ventricles indicating to the heart failure causing death. Hence, growing awareness for this disease may boost chagas disease drug market growth in near future. 

Market Dynamics

Increasing population suffering from chagas disease and increase in research and development (R&D) of innovative products are some of the key drivers for this market growth. Conversely, lack of awareness for treatment, limited approved products in present market, and supply chain problems associated to chagas disease drugs will restraint growth of this market in near future. Rising incidences of chagas disease owing to unhygienic surroundings is expected to boost the growth of this market.

Market Classification

The market can be bifurcated on the basis of drug type, treatment type, distribution channel, and geography. By drug type, chagas disease drug market can be segmented into benznidazole, nifurtimox and others. By treatment type, chagas disease drug market can be segmented into antiparasitic treatment and symptomatic treatment. By distribution channel, chagas disease drug market can be segmented into hospital pharmacies, online pharmacies and retail pharmacies. On the basis of geography, the chagas disease drug market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market

Chagas Disease Drug Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Drug Type, Treatment Type, Distribution Channel, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major players involved in chagas disease drug market include AstraZeneca Plc, Bayer AG, Daiichi Sankyo Co Ltd, Eisai Co Ltd, GlaxoSmithKline Plc, Grupo Praxis Pharmaceutical SA, Humanigen Inc, Kancera AB, Merck & Co Inc, Novartis AG, Oblita Therapeutics BVBA, and Sanofi SA among others.

Market Segmentation

Market By Drug Type

  • Benznidazole
  • Nifurtimox
  • Others

Market By Treatment Type

  • Antiparasitic Treatment
  • Symptomatic Treatment

Market By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

ECG Equipment and Management Systems Market (By Product Type: Holter Monitors, Resting ECG System, Stress ECG Monitors, Event Monitoring Systems, ECG Management Systems; By End Use: Hospitals & Clinics, Ambulatory Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction ECG Equipment and Management Systems is a gadget which records the heart exercises through electric signals and are enhanced on the ECG screen. ECG Equipment and Management Systems are utilized to analyze sorts of heart illnesses and arrhythmias in an individual's body in this manner help the suitable treatment. The ECG test is noninvasive and effortless method and decides irregularity designs

Macular Degeneration Treatment Market (By Disease Indication: Dry Age-related Macular Degeneration Treatment, Wet Age-related Macular Degeneration Treatment, Others; By Drug Class: Anti-vascular endothelial growth factor, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global macular degeneration treatment Market is estimated to value US$ 11.4 Billion by 2026 and the market is projected to showcase 6.6% CAGR during the forecast period. The macular degeneration treatment market is driven by surge in healthcare spending and improved in healthcare infrastructure. Market D

Gynecological Devices Market (By Device: Surgical Devices [Endoscopy Devices, Fluid Management Systems, Endometrial Ablation Devices, Contraceptive Devices, Others], Diagnostic Imaging Systems [Ultrasound, Mammography, MRI, Others], Hand Held Instruments [Biopsy Forceps, Tenaculum, Curettes, Others], Software, Others; By End-Users: Hospitals, Clinics, Diagnostic Centres, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Gynecological Devices market was valued at $9.4 billion in 2018 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Gynecological devices include instruments and devices used for the treatment of diseases related to the female reproductive system. These devices include surgical devices, handheld instruments, diagnostic i

Transfusion Technology Market (By Product: Instruments [Apheresis System & Multicomponent Collection Systems, Cell Processing Systems & Cell Expansion Systems, Auto Transfusion Devices, Others], Disposables & Consumables; By End-user: Hospitals, Blood Banks, Biotechnology & Pharmaceutical Companies, Others ) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The international transfusion technology market’s worth is likely to touch USD 7,138 Million by 2026 and the market is expected to project a CAGR of 5.4% during the upcoming years. Market Dynamics The worldwide transfusion technology market is described by

Cart Summary